Celcuity, Inc. (CELC)
114.53
-0.71
(-0.62%)
USD |
NASDAQ |
Mar 06, 15:48
Celcuity Cash from Investing (TTM) : -129.93M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Praxis Precision Medicines, Inc. | -311.15M |
| Rhythm Pharmaceuticals, Inc. | -137.15M |
| Apogee Therapeutics, Inc. | -179.57M |
| Arrowhead Pharmaceuticals, Inc. | -229.95M |
| Cogent Biosciences, Inc. | -399.53M |